Background: Antivirals for the treatment of hepatitis C virus (HCV) infection are effective, but many patients remain untreated and treatment is not yet routine in primary care. We evaluated the characteristics of patients who engaged in HCV treatment, and clinician perspectives on the barriers and facilitators to treatment.
Methods: Our mixed-method, parallel-design study was conducted at a multisite primary care centre in downtown Toronto.